Moleculin Biotech
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MBRX and other ETFs, options, and stocks.About MBRX
Moleculin Biotech, Inc. is a clinical stage pharmaceutical company. It engages in the business of growing a pipeline including phase 2 clinical programs for hard-to-treat cancers and viruses.
MBRX Key Statistics
Stock Snapshot
The current Moleculin Biotech(MBRX) stock price is $2.49, with a market capitalization of 13.29M. The stock trades at a price-to-earnings (P/E) ratio of -0.06.
On 2026-03-25, Moleculin Biotech(MBRX) stock traded between a low of $2.28 and a high of $2.50. Shares are currently priced at $2.49, which is +9.5% above the low and -0.4% below the high.
The Moleculin Biotech(MBRX)'s current trading volume is 199.11K, compared to an average daily volume of 112.84K.
During the past year, Moleculin Biotech(MBRX) stock moved between $1.79 at its lowest and $28.75 at its peak.
During the past year, Moleculin Biotech(MBRX) stock moved between $1.79 at its lowest and $28.75 at its peak.
MBRX News
Moleculin Biotech (MBRX) announced that the 45th subject has been enrolled in its pivotal Phase 2B/3 MIRACLE trial evaluating Annamycin in combination with cyta...
The latest announcement is out from Moleculin Biotech ( (MBRX) ). On March 23, 2026, Moleculin Biotech announced enrollment of the 45th subject in its pivotal...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.